The global market for medicated boluses for ruminants is expected to expand through 2035, according to new IndexBox market research.
Medicated boluses provide an alternative to repeated liquid or injectable administration by delivering veterinary medicines or nutritional compounds orally over an extended period.
Anthelmintic boluses represent a major application, while trace-mineral and combination formulations are also gaining attention.
The commercial attraction is straightforward: a long-acting bolus can potentially reduce labour requirements, simplify administration and improve dosing consistency in large herds and flocks.
The category also sits at the intersection of veterinary pharmaceuticals and livestock nutrition. Combination products that deliver medicines plus trace minerals or other nutrients could provide additional opportunities for producers.
For emerging markets such as India, where herd sizes can be large and veterinary access uneven, long-acting delivery formats could have practical relevance if cost, formulation stability and farmer usability are appropriate.
